LifeSiteNews has been permanently banned on YouTube. Click HERE to sign up to receive emails when we add to our video library.
April 14, 2021 (Children’s Health Defense) — A new study by Israeli researchers found that a South African variant of COVID may put people who have been vaccinated with the Pfizer-BioNTech vaccine at higher risk of breakthrough infection compared to unvaccinated people.
The study also showed an increased incidence of the UK variant in those who received one dose of the Pfizer shot.
The study, released April 10, reviewed the positive COVID-19 test results of 800 people — 400 people who tested positive for COVID 14 days or more after they received one or two doses of the Pfizer vaccine against 400 unvaccinated people to see if those vaccinated were more likely to be infected with the UK or South African variant compared with unvaccinated individuals.
The South African variant, B.1.351, was found to make up about 1% of all COVID cases across all the people studied, according to the study by Tel Aviv University and Israel’s largest healthcare provider, Clalit.
But among patients who had received two doses of the vaccine, the variant’s prevalence rate was eight times higher than in those unvaccinated — 5.4% versus 0.7%, Reuters
The remainder of this article is available in its entirety at LifeSite News
The views expressed in this news alert by the author do not directly represent that of The Official Street Preachers or its editors